Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
TROV [NASD]
TrovaGene, Inc.
Index- P/E- EPS (ttm)-1.10 Insider Own14.93% Shs Outstand18.91M Perf Week-11.17%
Market Cap94.74M Forward P/E- EPS next Y-0.63 Insider Trans- Shs Float16.34M Perf Month-20.22%
Income-17.10M PEG- EPS next Q-0.20 Inst Own23.20% Short Float3.90% Perf Quarter-16.92%
Sales0.40M P/S236.85 EPS this Y-287.00% Inst Trans-200.32% Short Ratio10.37 Perf Half Y-29.14%
Book/sh1.18 P/B4.25 EPS next Y17.10% ROA-119.90% Target Price10.00 Perf Year-14.07%
Cash/sh1.47 P/C3.41 EPS next 5Y- ROE-326.50% 52W Range4.02 - 10.27 Perf YTD-12.72%
Dividend- P/FCF- EPS past 5Y0.00% ROI-218.20% 52W High-51.22% Beta-0.82
Dividend %- Quick Ratio20.00 Sales past 5Y- Gross Margin- 52W Low24.63% ATR0.36
Employees21 Current Ratio20.00 Sales Q/Q-71.00% Oper. Margin- RSI (14)38.97 Volatility11.62% 6.42%
OptionableYes Debt/Eq0.02 EPS Q/Q-400.00% Profit Margin- Rel Volume1.51 Prev Close4.47
ShortableYes LT Debt/Eq0.02 EarningsNov 11 Payout- Avg Volume61.45K Price5.01
Recom2.00 SMA20-11.34% SMA50-15.22% SMA200-24.61% Volume92,496 Change12.08%
13-Nov-13Reiterated Aegis Capital Buy $14 → $10
01-Oct-13Reiterated Aegis Capital Buy $14
16-Jul-13Initiated Cantor Fitzgerald Buy $10
01-Apr-13Reiterated Aegis Capital Buy $12 → $14
12-Dec-12Initiated Aegis Capital Buy $12
16-Apr-14 06:03PM  Nasdaq stocks posting largest percentage increases AP +12.08%
10:47AM  TrovaGene (TROV) Enters Oversold Territory Zacks
14-Apr-14 10:18AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online -6.98%
08-Apr-14 04:03PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
11:08AM  Trovagene says diagnostic platform demonstrates ability to monitor mutations at theflyonthewall.com
11:00AM  Clinical Data Presented at AACR Demonstrate Ability of Trovagene's Molecular Diagnostic Platform to Non-Invasively Track Cancer Patients' Response to Therapy PR Newswire
01-Apr-14 08:00AM  Trovagene Announces Clinical Data Presentation for Its Oncogene Mutation Monitoring Platform at the American Association for Cancer Research Annual Meeting PR Newswire
31-Mar-14 06:54AM  Weakness Seen in MannKind (MNKD): Stock Falls 7.1% Zacks +5.91%
26-Mar-14 08:00AM  Genomics and Molecular Diagnostics Pioneer Charles Cantor, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
21-Mar-14 01:04PM  TROVAGENE, INC. Financials EDGAR Online Financials
19-Mar-14 08:00AM  Trovagene and Catholic Health Initiatives Center for Translational Research Partner to Clinically Evaluate Non-Invasive Genomic Diagnostics to Improve Cancer Care PR Newswire
17-Mar-14 10:05PM  TrovaGene's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha +6.53%
04:11PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements EDGAR Online
04:01PM  TROVAGENE, INC. Files SEC form 10-K, Annual Report EDGAR Online
04:00PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire
08:00AM  Trovagene Releases Its First Oncogene Mutation Assay Using Next Generation Sequencing, Expands Its Non-Invasive Cancer Monitoring Platform PR Newswire
03-Mar-14 08:00AM  Trovagene Schedules Release of Fourth Quarter and Year End 2013 Financial Results and Investor Conference Call PR Newswire
19-Feb-14 08:10AM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
08:00AM  Dr. Rodney S. Markin Joins Trovagene's Board of Directors PR Newswire
11-Feb-14 06:02AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
06-Feb-14 08:00AM  Trovagene to Present at Two Upcoming Investor Conferences PR Newswire
05-Feb-14 11:40AM  Myriad Genetics rallies after buying rival, increasing 2014 outlook at theflyonthewall.com
11:40AM  Myriad Genetics rallies after buying rival, increasing 2014 outlook
21-Jan-14 07:04AM  Trovagene Is Developing A New Standard Of Care To Manage Cancer, Says CEO at Seeking Alpha
07:04AM  Trovagene Is Developing A New Standard Of Care To Manage Cancer, Says CEO
13-Jan-14 09:13AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
09:13AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure
06-Jan-14 09:18AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:18AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:00AM  Trovagene and US Oncology Research Collaborate on a Prospective Study for Urine-based KRAS Testing in Patients with Metastatic Pancreatic Cancer PR Newswire
05:00AM  Trovagene and US Oncology Research Collaborate on a Prospective Study for Urine-based KRAS Testing in Patients with Metastatic Pancreatic Cancer
30-Dec-13 04:21PM  Trovagene: Strong Biotech 'January Effect' Candidate For 2014 at Seeking Alpha
04:21PM  Trovagene: Strong Biotech 'January Effect' Candidate For 2014
27-Dec-13 05:59PM  Nasdaq stocks posting largest percentage increases AP +5.94%
01:28PM  Nasdaq stocks posting largest percentage increases AP
26-Dec-13 05:54PM  Nasdaq stocks posting largest percentage increases AP +5.30%
01:42PM  Nasdaq stocks posting largest percentage increases AP
02-Dec-13 05:00AM  Trovagene to Present at 25th Annual Piper Jaffray Conference PR Newswire
05:00AM  Trovagene to Present at 25th Annual Piper Jaffray Conference
22-Nov-13 11:07AM  Empire Asset Management terminates coverage on TrovaGene (NASDAQ:TROV). PR Newswire
11:07AM  Empire Asset Management terminates coverage on TrovaGene (NASDAQ:TROV).
14-Nov-13 09:48PM  TrovaGene's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
09:48PM  TrovaGene's CEO Discusses Q3 2013 Results - Earnings Call Transcript
04:47PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:47PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:14PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:14PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report
04:00PM  Trovagene, Inc. Reports Third Quarter 2013 Financial Results PR Newswire
04:00PM  Trovagene, Inc. Reports Third Quarter 2013 Financial Results
08-Nov-13 05:00AM  Trovagene Schedules Release of Third Quarter 2013 Financial Results and Hosts Investor Conference Call PR Newswire +7.14%
30-Oct-13 04:20PM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04:00PM  Dr. Paul Billings Joins Trovagene's Board of Directors PR Newswire
22-Oct-13 08:47AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
21-Oct-13 12:38PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:31PM  InPlay: TrovaGene: First prospective cancer monitoring data released - indicating that oncogene mutation signal in urine correlates with response to therapy Briefing.com
12:30PM  First Prospective Cancer Monitoring Data Released - Indicating that Oncogene Mutation Signal in Urine Correlates with Response to Therapy PR Newswire
16-Oct-13 05:53AM  Trovagene announces pharmaceutical collaboration for oncogene mutation study theflyonthewall.com
05:00AM  Trovagene announces pharmaceutical collaboration for oncogene mutation detection study PR Newswire
14-Oct-13 05:00AM  Trovagene Announces Abstracts to be Presented at Molecular Targets and Cancer Therapeutics Conference PR Newswire
01-Oct-13 06:02PM  Nasdaq stocks posting largest percentage increases AP +13.51%
05:40PM  4 Healthcare Stock Stories Making a Big Buzz Today at Wall St. Cheat Sheet
01:22PM  Nasdaq stocks posting largest percentage increases AP
05:00AM  First urine-based cancer mutation monitoring test available from Trovagene PR Newswire
25-Sep-13 02:00PM  You Could Double Your Money With This Future Medical Superstar StreetAuthority Network
05:00AM  Trovagene Expands NPM Patent Coverage PR Newswire
06-Sep-13 07:52PM  4 Healthcare Stock Stories for Weekend Investment Wellness at Wall St. Cheat Sheet
03:05PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:00AM  Trovagene collaborates with USC in clinical study evaluating cancer monitoring technology PR Newswire
04-Sep-13 05:00AM  Trovagene to Present at Two Healthcare Conferences PR Newswire
03-Sep-13 06:03PM  Nasdaq stocks posting largest percentage decreases AP
01:17PM  Nasdaq stocks posting largest percentage decreases AP
30-Aug-13 06:05PM  Nasdaq stocks posting largest percentage decreases AP -9.49%
01:40PM  Nasdaq stocks posting largest percentage decreases AP
09:06AM  Can Trovagene Be The Belle Of The Ball? at Seeking Alpha
21-Aug-13 01:04PM  TROVAGENE, INC. Financials EDGAR Online Financials
14-Aug-13 05:57PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online +5.02%
05:46PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:45PM  Trovagene, Inc. Announces Second Quarter 2013 Earnings PR Newswire
08-Aug-13 06:04PM  Nasdaq stocks posting largest percentage decreases AP
01:16PM  Nasdaq stocks posting largest percentage decreases AP
07-Aug-13 06:02PM  Nasdaq stocks posting largest percentage decreases AP +6.06%
01:22PM  Nasdaq stocks posting largest percentage decreases AP
06-Aug-13 06:03PM  Nasdaq stocks posting largest percentage decreases AP -9.45%
03:49AM  U.K. Asset Resolution Says Repaid Taxpayers 1.9 Billion Pounds at Bloomberg
05-Aug-13 08:37AM  2 Health Care Stocks Rising on Big Volume at TheStreet
03-Aug-13 12:02AM  Does Exact Sciences' $1B Valuation Foreshadow A Bright Future For TrovaGene? at Seeking Alpha
31-Jul-13 10:01AM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
06:03AM  Trovagene raised $15M in a registered direct offering at theflyonthewall.com
05:00AM  Trovagene, Inc. Announces Closing of $15 Million Registered Direct Offering of Common Stock PR Newswire
29-Jul-13 05:00AM  RainDrop System Unlocks Power of Trovagene's Urine-Based Mutation Detection Technology PR Newswire
28-Jul-13 11:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
25-Jul-13 03:30PM  TrovaGene: A Stock Filled With Freebies at Seeking Alpha
24-Jul-13 07:04PM  4 Healthcare Stock Stories For a Midweek Investment Checkup at Wall St. Cheat Sheet
09:58AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:22AM  InPlay: TrovaGene announced issuance of broad MicroRNA patent Briefing.com
05:00AM  Trovagene Announces Issuance of Broad MicroRNA Patent PR Newswire
23-Jul-13 06:23PM  Nasdaq stocks posting largest percentage increases AP
01:28PM  Nasdaq stocks posting largest percentage increases AP
22-Jul-13 11:04PM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online +21.31%
06:02PM  Nasdaq stocks posting largest percentage increases AP
Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. Its technology is used in the detection and monitoring of diseases in various medical disciplines, primarily the management of cancer treatment. The company's proprietary urine-based molecular diagnostic tests are used to detect cell-free DNA and RNA originating from normal and diseased cell death that can be isolated and detected from urine. Its technology is applied in various testing, such as tumor mutation detection and monitoring, infectious disease monitoring, transplantation monitoring, and prenatal genetic diagnostics. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.